Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,6.717676053654212e-40,21.691570590614887,1956.5506320300483,"['RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS5', 'RPSA', 'RPS3A', 'RPL24', 'RPL26', 'RPL29', 'UBA52', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS23']",3.0229542241443955e-37,0,0,55
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.642835697864811e-22,10.380362376765255,507.8746474784084,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UQCRFS1', 'ATP5MF', 'COX8A', 'ATP5PF', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6']",1.2696380320195824e-19,0,0,40
3,Nonalcoholic fatty liver disease WP4396,7.577605021038805e-13,4.856731473329988,135.5436484554721,"['NDUFA13', 'COX7B', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'SOCS3', 'LEPR', 'UQCRFS1', 'CCL2', 'COX8A', 'XBP1', 'JUN', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS']",1.1366407531558206e-10,0,0,38
4,Mitochondrial CIV Assembly WP4922,1.7051086481730248e-11,13.891784406070121,344.4441158869022,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",1.9182472291946528e-09,0,0,17
5,Oxidative phosphorylation WP623,3.0276326379047145e-10,7.918580746681556,173.5600065000237,"['ATP5PF', 'NDUFB7', 'NDUFA6', 'NDUFA11', 'ATP6AP1', 'NDUFB10', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFB2', 'NDUFC2', 'ATP5MC3', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'ATP5MF']",2.724869374114243e-08,0,0,20
6,Mitochondrial complex I assembly model OXPHOS system WP4324,2.7963111881772486e-06,5.238244514106583,66.98252971109763,"['NDUFA13', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAF3']",0.00020972333911329364,0,0,15
7,Computational Model of Aerobic Glycolysis WP4629,3.7159690236534525e-06,21.298481308411215,266.29216584946073,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ENO1', 'ALDOA', 'GAPDH']",0.00023888372294915053,0,0,7
8,Selenium Micronutrient Network WP15,1.466794112795417e-05,3.922069843902728,43.652034624440525,"['GPX4', 'GPX3', 'PLG', 'KMO', 'SELENOK', 'SELENOH', 'SOD1', 'PRDX2', 'SELENOM', 'PRDX5', 'RFK', 'PRDX1', 'SELENOW', 'SELENOV', 'CCL2', 'SEPHS2', 'MSRB1']",0.0007725614224466885,0,0,17
9,Glycolysis and Gluconeogenesis WP534,1.545122844893377e-05,5.631202261382089,62.381456559571625,"['LDHA', 'TPI1', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'ALDOC', 'ENO1', 'ENO2', 'ALDOA', 'GAPDH', 'HK2']",0.0007725614224466885,0,0,12
10,Mitochondrial complex III assembly WP4921,5.5141578893363265e-05,10.646514797507788,104.39553489789532,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.002481371050201347,0,0,7
11,Glycolysis in senescence WP5049,6.442116830156408e-05,14.59237354085603,140.81740101506418,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.0026354114305185304,0,0,6
12,Cori Cycle WP1946,0.00020936676564852776,10.421789883268483,88.28739035575134,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.007851253711819791,0,0,6
13,IL-18 signaling pathway WP4754,0.0002622085731066871,2.1105673558977514,17.4045199394522,"['MTCH1', 'CEBPB', 'NRN1', 'CD81', 'MEPCE', 'COX17', 'HSPB1', 'ENO1', 'FUT1', 'SOCS3', 'TMSB4X', 'STMN1', 'HMOX1', 'CCL2', 'MAPK3', 'SLC12A3', 'JUN', 'IMP3', 'BAD', 'FN1', 'IL18', 'NDUFC1', 'FOS', 'NR4A1', 'ARL4D', 'CYCS', 'PTPN7', 'NFKBIE', 'ATF3', 'ITM2C', 'ARF6', 'MYH7']",0.009076450607539168,0,0,32
14,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.0012277131105447885,3.178774178196281,21.306058481842523,"['FZD1', 'CDKN1A', 'JUN', 'CDKN1B', 'TMSB4X', 'FN1', 'NEFL', 'NEFM', 'ELK1', 'NEFH', 'PFN2', 'SOD1']",0.037247041944755435,0,0,12
15,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0012415680648251812,1.671328846640336,11.183496634855905,"['SET', 'HSPB1', 'CRIP2', 'RPL10A', 'ELK1', 'FUT1', 'APOLD1', 'RPL7', 'ACTG1', 'PRDX2', 'LDHA', 'RPL18A', 'TMSB4X', 'DNAJB4', 'CFL1', 'AP2S1', 'PGK1', 'RPLP2', 'CCL2', 'DNAJB9', 'SH3BGRL3', 'ATP6V1E1', 'CCT7', 'IER5', 'TMSB10', 'MAPK3', 'EGR1', 'JUN', 'HSP90AA1', 'SDF2L1', 'EGR3', 'SSR4', 'FN1', 'DKK1', 'SELE', 'DNAJA1', 'NR4A1', 'RCN1', 'CYCS', 'RPL26', 'CALR', 'ALDOA', 'DSC1', 'GAPDH', 'SLC25A11', 'FJX1', 'EIF4G2', 'ARF6']",0.037247041944755435,0,0,48
16,Myometrial relaxation and contraction pathways WP289,0.001484970805990443,2.230989387196166,14.529006416360952,"['JUN', 'PRKCH', 'YWHAB', 'FOS', 'ACTB', 'ACTG1', 'RGS4', 'CREB3', 'RGS2', 'GNG3', 'ACTC1', 'PRKAR1A', 'CRH', 'GNG8', 'CALM3', 'IGFBP6', 'CALM1', 'CALM2', 'ATF3', 'YWHAG', 'YWHAH']",0.04176480391848121,0,0,21
17,Proximal tubule transport WP4917,0.002082338328269922,3.3816896521814557,20.879444071355163,"['ATP6V1G1', 'ATP6V0B', 'SLC22A6', 'SLC3A1', 'ATP6V0A4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ATP6V1B1', 'ATP6V1F']",0.05512072045420382,0,0,10
18,Exercise-induced Circadian Regulation WP410,0.0024675331247317974,3.2900816507373882,19.755414906909383,"['PER2', 'DNAJA1', 'HSPA8', 'CEBPB', 'BTG1', 'RBPMS', 'TUBB3', 'GSTP1', 'SUMO3', 'EIF4G2']",0.06168832811829494,0,0,10
19,"GPCRs, Class A Rhodopsin-like WP455",0.009117568376654905,1.9770280885756142,9.287192520051748,"['GPR87', 'OR2H2', 'HTR2B', 'ADRA1D', 'GPR3', 'SSTR1', 'GPR6', 'MCHR1', 'SSTR3', 'HCRTR1', 'MC4R', 'MAS1', 'OPN1SW', 'GPR171', 'RHO', 'ACKR4', 'RGL4', 'GPR18']",0.20971731106175998,0,0,18
20,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.00959504441201737,2.478978587962963,11.518595132025713,"['PSMD8', 'HSPA8', 'TUBA1A', 'TUBB2A', 'HSPA5', 'TUBB3', 'TUBB', 'STUB1', 'TUBB4B', 'TUBA4A', 'HSPA1B']",0.20971731106175998,0,0,11
21,Photodynamic therapy-induced unfolded protein response WP3613,0.0097868078495488,3.836657792340774,17.751141102968663,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'ATF3']",0.20971731106175998,0,0,6
22,Dual hijack model of Vif in HIV infection WP3300,0.012276086497749793,9.09957298136646,40.03905014950449,"['UBB', 'ELOB', 'RUNX1']",0.24953693874025565,0,0,3
23,Spinal Cord Injury WP2431,0.012754110202279734,2.104662741572165,9.180331970440415,"['EGR1', 'CDKN1B', 'GADD45A', 'MIF', 'FOS', 'PDYN', 'NTN1', 'TNFSF13B', 'RHOB', 'SELP', 'NR4A1', 'ZFP36', 'CCL2', 'MAPK3']",0.24953693874025565,0,0,14
24,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.014358816100776205,3.470817120622568,14.728034698026457,"['EGR2', 'RAB3A', 'RAB25', 'HSPB1', 'NEFL', 'RABAC1']",0.26922780188955386,0,0,6
25,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.015119343940610567,4.047693105235873,16.9670402163158,"['H2AFZ', 'H2AFX', 'DUSP6', 'HIST1H3E', 'MAPK3']",0.2721481909309902,0,0,5
26,Glucocorticoid Receptor Pathway WP2880,0.016353783226509967,2.3847790482313145,9.809302163865059,"['RGS2', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'TSC22D3', 'B3GNT5', 'ENC1', 'BHLHE40', 'CCL2']",0.28304624815113405,0,0,10
27,Galanin receptor pathway WP4970,0.018165888996803475,4.855011655011655,19.459904685004233,"['POMC', 'CDKN1A', 'CDKN1B', 'FOS']",0.2876674619191628,0,0,4
28,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.018538569768123826,7.279192546583851,29.028705531163975,"['HSD11B1', 'HSD11B2', 'HSD3B1']",0.2876674619191628,0,0,3
29,HIF1A and PPARG regulation of glycolysis WP2456,0.018538569768123826,7.279192546583851,29.028705531163975,"['LDHA', 'TPI1', 'GAPDH']",0.2876674619191628,0,0,3
30,Complement system WP2806,0.019966279904064778,2.1935194672131146,8.584800024106976,"['SELP', 'PRNP', 'FKBP2', 'RPS19', 'SELL', 'F12', 'MASP2', 'PLG', 'CD59', 'CALR', 'SELE']",0.29949419856097165,0,0,11
31,Melanoma WP4685,0.02237336649451804,2.2518576343712957,8.55679784763386,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'CALM3', 'FOS', 'CALM1', 'ELK1', 'CALM2', 'MAPK3']",0.3178183100548463,0,0,10
32,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.022628497085154194,3.571036501692434,13.529033319072633,"['JUN', 'SRXN1', 'GSTP1', 'HMOX1', 'FOS']",0.3178183100548463,0,0,5
33,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.023306676070688728,4.413364413364413,16.58990494046187,"['CD63', 'CD81', 'HSPB1', 'SOD1']",0.3178183100548463,0,0,4
34,MAPK pathway in congenital thyroid cancer WP4928,0.02924350280936524,4.045325045325045,14.288483920036619,"['JUN', 'FOS', 'ELK1', 'MAPK3']",0.38254117908827706,0,0,4
35,Alzheimer's disease WP2059,0.03130118183580203,2.0266927083333335,7.020665043190651,"['PSENEN', 'ATP5MD', 'CDK5', 'BAD', 'LPL', 'CYCS', 'CALM3', 'CALM1', 'GAPDH', 'CALM2', 'MAPK3']",0.38254117908827706,0,0,11
36,COVID-19 adverse outcome pathway WP4891,0.03145338583614723,12.124903025601242,41.94305434852685,"['IL7', 'CCL2']",0.38254117908827706,0,0,2
37,Thyroxine (Thyroid Hormone) Production WP1981,0.03145338583614723,12.124903025601242,41.94305434852685,"['TPO', 'CGA']",0.38254117908827706,0,0,2
38,Metabolic reprogramming in colon cancer WP4290,0.03382573399216337,2.500893347993403,8.469358866488145,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'ENO1', 'GAPDH']",0.3958507614460371,0,0,7
39,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.034307065991989884,1.7388235294117647,5.864015322299087,"['EGR1', 'TPH1', 'JUN', 'CEBPB', 'TSPYL1', 'YWHAB', 'SSTR1', 'ADCYAP1', 'PRKAR1A', 'KCNQ1', 'BHLHE40', 'ALDOA', 'GAPDH', 'SLC25A4', 'YWHAG', 'YWHAH']",0.3958507614460371,0,0,16
40,CAMKK2  Pathway WP4874,0.03644952200765473,2.698486813661911,8.936921311225683,"['FIS1', 'WFS1', 'HMOX1', 'CALM1', 'CALM2', 'MAPK3']",0.4100571225861157,0,0,6
41,Pathogenic Escherichia coli infection WP2272,0.03803388774554649,2.260399862241476,7.389874939291989,"['TUBA1A', 'TUBB2A', 'TUBB3', 'TUBB', 'TUBB4B', 'ACTB', 'TUBA4A', 'ACTG1']",0.41744510940233953,0,0,8
42,Kynurenine Pathway and links to Cellular Senescence WP5044,0.04356724309339309,3.466977466977467,10.863599559957585,"['CDKN1A', 'HAAO', 'KMO', 'ACMSD']",0.4667918902863545,0,0,4
43,Sulfation Biotransformation Reaction WP692,0.045996870925415115,4.548621894409938,14.006034244360645,"['SULT1C2', 'SULT4A1', 'SULT1C4']",0.4704225435553818,0,0,3
44,Transcriptional cascade regulating adipogenesis WP4211,0.045996870925415115,4.548621894409938,14.006034244360645,"['CEBPB', 'EGR2', 'DDIT3']",0.4704225435553818,0,0,3
45,Pathways in clear cell renal cell carcinoma WP4018,0.050177930326009625,1.8570855034722222,5.5567340718660905,"['LDHA', 'TPI1', 'PKM', 'BHLHE41', 'PGK1', 'ALDOC', 'ENO1', 'ENO2', 'ALDOA', 'GAPDH', 'HK2']",0.5017793032600962,0,0,11
46,Androgen receptor signaling pathway WP138,0.05393831615866671,1.8315282534246575,5.347905315846364,"['CDKN1A', 'JUN', 'PRDX1', 'BAG1', 'RNF6', 'STUB1', 'CALR', 'FKBP4', 'ETV5', 'RAN', 'RHOB']",0.5276574406826091,0,0,11
47,Genes targeted by miRNAs in adipocytes WP1992,0.057944575510215195,4.04296066252588,11.515436773912219,"['KCNE1', 'TMSB4X', 'KCNQ1']",0.5432303954082675,0,0,3
48,Platelet-mediated interactions with vascular and circulating cells WP4462,0.057944575510215195,4.04296066252588,11.515436773912219,"['SELP', 'CCL2', 'SELE']",0.5432303954082675,0,0,3
49,Oxidative Damage WP3941,0.059231224267567335,2.34969248148613,6.640950990531194,"['CDKN1A', 'CDKN1B', 'BAD', 'GADD45A', 'CYCS', 'NFKBIE']",0.5439602228654143,0,0,6
50,Adipogenesis WP236,0.06739381957355058,1.6635203031051808,4.486850227009297,"['FZD1', 'EGR2', 'CDKN1A', 'CEBPB', 'GADD45B', 'GADD45A', 'HMGA1', 'LPL', 'MIF', 'SOCS3', 'CYP26B1', 'DDIT3', 'NDN']",0.6065443761619552,0,0,13
51,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.07097619675518332,6.061675717610551,16.035621894957256,"['COX8A', 'GSTP1']",0.6078895591950357,0,0,2
52,IL-7 signaling pathway WP205,0.07118530799009293,2.854609442844737,7.543216475427895,"['CDKN1B', 'BAD', 'IL7', 'MAPK3']",0.6078895591950357,0,0,4
53,Circadian rhythm related genes WP3594,0.07210718695648756,1.4913978494623656,3.921782110429038,"['NTRK1', 'EGR1', 'TPH1', 'JUN', 'EGR3', 'CAVIN3', 'BHLHE41', 'CARTPT', 'NR2F6', 'RELB', 'HCRTR1', 'PER2', 'UBC', 'BHLHE40', 'CRH', 'GHRL', 'RPS27A', 'UBA52', 'SKP1']",0.6078895591950357,0,0,19
54,Metapathway biotransformation Phase I and II WP702,0.07303623653841099,1.605694360307915,4.201780311698042,"['CHST9', 'GPX4', 'GPX3', 'GSTP1', 'GLYAT', 'CYP2C18', 'CYP39A1', 'SULT1C2', 'CYP26B1', 'CYP2A6', 'GAL3ST2', 'NAT8L', 'SULT4A1', 'SULT1C4']",0.6078895591950357,0,0,14
55,Sleep regulation WP3591,0.07429761279050437,2.4270606531881804,6.309572440067217,"['IL18', 'CRH', 'GHRL', 'FOS', 'HCRTR1']",0.6078895591950357,0,0,5
56,Oncostatin M Signaling Pathway WP2374,0.07813013285082376,1.9048492350954411,4.856183538337195,"['SOCS3', 'EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'CCL2', 'FOS', 'MAPK3']",0.6278314246941196,0,0,8
57,Cardiac Progenitor Differentiation WP2406,0.08328537203118518,2.3335626271085057,5.80002872486003,"['MESP1', 'ACTC1', 'THY1', 'DKK1', 'NODAL']",0.6504171566970541,0,0,5
58,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.08383154464095365,1.7918979054244137,4.442017992083908,"['CDKN1A', 'JUN', 'GADD45B', 'BAD', 'GADD45A', 'CYCS', 'FOS', 'NTN1', 'MAPK3']",0.6504171566970541,0,0,9
59,Calcium Regulation in the Cardiac Cell WP536,0.09056140355778382,1.519494514106583,3.649411253113082,"['PRKCH', 'YWHAB', 'ADRA1D', 'RGS4', 'RGS2', 'GNG3', 'PLN', 'PRKAR1A', 'GNG8', 'CALM3', 'CALR', 'CALM1', 'CALM2', 'YWHAG', 'YWHAH']",0.68236335037062,0,0,15
60,Translation Factors WP107,0.090981780049416,1.9312694704049844,4.629438345120432,"['EIF4A2', 'EEF1B2', 'EIF5A', 'EEF1G', 'EIF1AX', 'EEF1A2', 'EIF1']",0.68236335037062,0,0,7
61,Endometrial cancer WP4155,0.09791413313164789,1.7986778672671113,4.1795236857352895,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'FOS', 'FGF1', 'ELK1', 'MAPK3']",0.7118221119090211,0,0,8
62,Genotoxicity pathway WP4286,0.09859128093727013,1.8882312218760817,4.374602073905577,"['PLK3', 'CDKN1A', 'RPS27', 'SERTAD1', 'GADD45A', 'PCDH8', 'TRIAP1']",0.7118221119090211,0,0,7
63,Blood Clotting Cascade WP272,0.10123692258261634,3.031638198757764,6.943335928361049,"['F8A1', 'F12', 'PLG']",0.7118221119090211,0,0,3
64,miRNAs involved in DNA damage response WP1545,0.10123692258261634,3.031638198757764,6.943335928361049,"['CDKN1A', 'CDKN1B', 'H2AFX']",0.7118221119090211,0,0,3
65,Amyotrophic lateral sclerosis (ALS) WP2447,0.10288497470980495,2.166601866251944,4.927163909089065,"['BAD', 'NEFL', 'NEFM', 'NEFH', 'SOD1']",0.7122805941448036,0,0,5
66,Physiological and pathological hypertrophy of the heart WP1528,0.10578155992720471,2.425951825951826,5.449607398281485,"['JUN', 'FOS', 'CALM1', 'CALM2']",0.7212379085945776,0,0,4
67,Pre-implantation embryo WP3527,0.11346718396984012,2.0917573872472786,4.552169468095945,"['EGR1', 'ZFP36', 'DDIT3', 'HMGA1', 'AQP3']",0.7467647807399097,0,0,5
68,Tryptophan metabolism WP465,0.11346718396984012,2.0917573872472786,4.552169468095945,"['TPH1', 'HAAO', 'DHCR24', 'CYP2C18', 'ACMSD']",0.7467647807399097,0,0,5
69,Serotonin and anxiety WP3947,0.11785079909446632,2.7982560917343524,5.983611371649681,"['POMC', 'CRH', 'FOS']",0.7467647807399097,0,0,3
70,Ovarian infertility WP34,0.11872917302020969,2.3102823102823105,4.923004224282757,"['EGR1', 'CEBPB', 'CDKN1B', 'MSH5']",0.7467647807399097,0,0,4
71,NAD Biosynthesis II (from tryptophan) WP2485,0.11976218648916395,4.04059994828032,8.575152256997825,"['HAAO', 'KMO']",0.7467647807399097,0,0,2
72,Apoptosis Modulation and Signaling WP1772,0.12363729655648953,1.6308007544182364,3.409030834124351,"['JUN', 'ENDOG', 'CAPNS1', 'BIK', 'BAD', 'PEA15', 'CYCS', 'FOS', 'MAPK3']",0.7467647807399097,0,0,9
73,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.1245470910897518,2.021902540176257,4.211767340689128,"['CREB3', 'HSD3B1', 'CALM3', 'CALM1', 'CALM2']",0.7467647807399097,0,0,5
74,NRF2 pathway WP2884,0.12666371686910305,1.502526941956909,3.104550621621928,"['EGR1', 'DNAJB1', 'HSP90AA1', 'CYP2A6', 'HSP90AB1', 'SRXN1', 'GPX3', 'FTH1', 'PRDX1', 'GSTP1', 'HMOX1', 'SLC5A3']",0.7467647807399097,0,0,12
75,BMP Signaling Pathway in Eyelid Development WP3927,0.13539152463353377,2.5982142857142856,5.1953490536358515,"['JUN', 'MAPK3', 'FGF10']",0.7467647807399097,0,0,3
76,Matrix Metalloproteinases WP129,0.13539152463353377,2.5982142857142856,5.1953490536358515,"['TIMP2', 'MMP19', 'TIMP4']",0.7467647807399097,0,0,3
77,Differentiation Pathway WP2848,0.13610402041709313,1.9565544574323985,3.902026657004079,"['TPO', 'FGF1', 'DKK1', 'NODAL', 'FGF10']",0.7467647807399097,0,0,5
78,IL-2 signaling pathway WP49,0.13610402041709313,1.9565544574323985,3.902026657004079,"['SOCS3', 'JUN', 'CISH', 'FOS', 'MAPK3']",0.7467647807399097,0,0,5
79,Breast cancer pathway WP4262,0.14278633904441895,1.4170843121900287,2.758221264071371,"['SHC4', 'FZD1', 'JUN', 'CDKN1A', 'GADD45B', 'GADD45A', 'FOS', 'FGF1', 'DLL3', 'FRAT2', 'HEY1', 'SKP1', 'FGF10', 'MAPK3']",0.7467647807399097,0,0,14
80,Bile acids synthesis and enterohepatic circulation  WP4389,0.14647919736910062,3.4631497284716835,6.652266853766887,"['FGFR4', 'MAPK3']",0.7467647807399097,0,0,2
81,Intraflagellar transport proteins binding to dynein WP4532,0.14651676353879553,2.1091179352048917,4.0508044504350655,"['DYNLT3', 'DYNLRB1', 'DYNLL1', 'DYNLL2']",0.7467647807399097,0,0,4
82,Oxidative Stress WP408,0.14651676353879553,2.1091179352048917,4.0508044504350655,"['GPX3', 'HMOX1', 'FOS', 'SOD1']",0.7467647807399097,0,0,4
83,"COVID-19, thrombosis and anticoagulation WP4927",0.1467659202468655,12.116279069767442,23.250125894971376,['PLG'],0.7467647807399097,0,0,1
84,Nicotine Metabolism WP1600,0.1467659202468655,12.116279069767442,23.250125894971376,['CYP2A6'],0.7467647807399097,0,0,1
85,G13 Signaling Pathway WP524,0.14811539859829512,1.8952906298600312,3.6195570350686466,"['CFL2', 'CFL1', 'ARHGDIG', 'CALM1', 'CALM2']",0.7467647807399097,0,0,5
86,IL1 and megakaryocytes in obesity WP2865,0.1537563884774804,2.4248447204968944,4.540244875417719,"['IL18', 'TIMP2', 'CCL2']",0.7467647807399097,0,0,3
87,Corticotropin-releasing hormone signaling pathway WP2355,0.15492189170620266,1.538529146799675,2.8691017914984056,"['POMC', 'NR4A1', 'HSP90AA1', 'HSD3B1', 'IL18', 'CRH', 'FOS', 'ELK1', 'MAPK3']",0.7467647807399097,0,0,9
88,Folate Metabolism WP176,0.1565546297491444,1.7330739299610896,3.213726089215043,"['GPX4', 'GPX3', 'RFK', 'CCL2', 'PLG', 'SOD1']",0.7467647807399097,0,0,6
89,IL-4 signaling pathway WP395,0.1565546297491444,1.7330739299610896,3.213726089215043,"['SOCS3', 'CEBPB', 'BAD', 'FOS', 'ELK1', 'MAPK3']",0.7467647807399097,0,0,6
90,Fas ligand pathway and stress induction of heat shock proteins WP314,0.16055700223792696,1.8377397615344737,3.3614212751212853,"['JUN', 'HSPB1', 'CYCS', 'ACTB', 'ACTG1']",0.7467647807399097,0,0,5
91,Ferroptosis WP4313,0.16055700223792696,1.8377397615344737,3.3614212751212853,"['PRNP', 'GPX4', 'FTH1', 'PCBP1', 'HMOX1']",0.7467647807399097,0,0,5
92,Vitamin A and carotenoid metabolism WP716,0.16055700223792696,1.8377397615344737,3.3614212751212853,"['CYP26B1', 'RBP4', 'RBP2', 'NPC1L1', 'LPL']",0.7467647807399097,0,0,5
93,MAPK Signaling Pathway WP382,0.16083059302835562,1.2854837243135115,2.3490976950520213,"['DUSP4', 'NTRK1', 'HSPA8', 'JUN', 'DUSP2', 'GADD45A', 'DUSP1', 'HSPB1', 'FOS', 'FGF1', 'ELK1', 'DUSP6', 'RELB', 'NR4A1', 'DDIT3', 'STMN1', 'PTPN7', 'FGFR4', 'HSPA1B', 'FGF10', 'CACNG5', 'MAPK3']",0.7467647807399097,0,0,22
94,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.16094207533120147,1.6333123652048886,2.9835892707942557,"['IFI27L2', 'JUN', 'PRKCH', 'CCL2', 'ISG15', 'RELB', 'MAPK3']",0.7467647807399097,0,0,7
95,Proteasome Degradation WP183,0.16094207533120147,1.6333123652048886,2.9835892707942557,"['PSMD8', 'PSMB6', 'UBB', 'H2AFZ', 'H2AFX', 'UBC', 'PSMB10']",0.7467647807399097,0,0,7
96,Aryl Hydrocarbon Receptor Pathway WP2873,0.16126971049001187,2.021108521108521,3.6878704253387187,"['HSP90AA1', 'JUN', 'CDKN1B', 'AIP']",0.7467647807399097,0,0,4
97,PDGFR-beta pathway WP3972,0.16126971049001187,2.021108521108521,3.6878704253387187,"['JUN', 'FOS', 'ELK1', 'MAPK3']",0.7467647807399097,0,0,4
98,Copper homeostasis WP3286,0.16768425166039572,1.692661297620125,3.0225387688424474,"['PRNP', 'JUN', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.7467647807399097,0,0,6
99,Imatinib and Chronic Myeloid Leukemia WP3640,0.17284263821783186,2.273146350931677,3.9902213300052245,"['SPRED2', 'CDKN1B', 'GADD45A']",0.7467647807399097,0,0,3
100,Nucleotide metabolism WP404,0.17284263821783186,2.273146350931677,3.9902213300052245,"['PRPS1', 'NME2', 'OAZ1']",0.7467647807399097,0,0,3
101,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.17284263821783186,2.273146350931677,3.9902213300052245,"['HTR2B', 'ELK1', 'MAPK3']",0.7467647807399097,0,0,3
102,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.17284263821783186,2.273146350931677,3.9902213300052245,"['EGR1', 'ELK1', 'MAPK3']",0.7467647807399097,0,0,3
103,ACE Inhibitor Pathway WP554,0.17424511550597893,3.0300620636152056,5.294403994904254,"['MAS1', 'ATP6AP2']",0.7467647807399097,0,0,2
104,Dopamine metabolism WP2436,0.17424511550597893,3.0300620636152056,5.294403994904254,"['TYR', 'SOD1']",0.7467647807399097,0,0,2
105,EDA signaling in hair follicle development WP3930,0.17424511550597893,3.0300620636152056,5.294403994904254,"['DKK1', 'RELB']",0.7467647807399097,0,0,2
106,Aryl Hydrocarbon Receptor Netpath WP2586,0.18662719725566979,1.7325038880248833,2.9082542239508617,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'AIP', 'LPL']",0.7724851458759449,0,0,5
107,Common Pathways Underlying Drug Addiction WP2636,0.18662719725566979,1.7325038880248833,2.9082542239508617,"['CALM1', 'CALM2', 'ACTB', 'ACTG1', 'MAPK3']",0.7724851458759449,0,0,5
108,NO/cGMP/PKG mediated Neuroprotection WP4008,0.18662719725566979,1.7325038880248833,2.9082542239508617,"['BAD', 'NEFL', 'CYCS', 'CALM1', 'CALM2']",0.7724851458759449,0,0,5
109,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.19088840780048927,1.6172243839169909,2.678230759745297,"['BEX3', 'SOCS3', 'CDKN1A', 'CDKN1B', 'HSPA5', 'HSPB1']",0.7724851458759449,0,0,6
110,Prolactin Signaling Pathway WP2037,0.19140545092498265,1.4932310090533005,2.4688503938909876,"['SOCS3', 'JUN', 'CISH', 'FOS', 'ELK1', 'CTSD', 'YWHAG', 'MAPK3']",0.7724851458759449,0,0,8
111,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.19226296964023515,1.86539955770725,3.07584093478141,"['NDUFA13', 'HSP90AA1', 'IL18', 'AAMP']",0.7724851458759449,0,0,4
112,Prion disease pathway WP3995,0.19226296964023515,1.86539955770725,3.07584093478141,"['PRNP', 'HSPA5', 'ELK1', 'MAPK3']",0.7724851458759449,0,0,4
113,Neuroinflammation WP4919,0.20274473370428472,2.693216102060167,4.297854618146673,"['JUN', 'FOS']",0.8000347435136642,0,0,2
114,Purine metabolism WP4792,0.20274473370428472,2.693216102060167,4.297854618146673,"['PRPS1', 'APRT']",0.8000347435136642,0,0,2
115,7q11.23 copy number variation syndrome WP4932,0.20445332334238084,1.394743689825657,2.214037859523088,"['ATP5F1B', 'CFL1', 'H2AFX', 'HMGA1', 'ATP5MC3', 'GAPDH', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'MAPK3']",0.8000347435136642,0,0,10
116,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.21277613028304973,2.020315734989648,3.1264682935448818,"['MDH2', 'SCO2', 'HMGA1']",0.8074383819439843,0,0,3
117,DNA damage response WP707,0.21401724795503838,1.48956113023993,2.296454412313111,"['CDKN1A', 'CDKN1B', 'GADD45B', 'CDK5', 'GADD45A', 'H2AFX', 'CYCS']",0.8074383819439843,0,0,7
118,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.21401724795503838,1.48956113023993,2.296454412313111,"['EGR1', 'JUN', 'CDKN1B', 'FOS', 'CGA', 'MYL12B', 'MAPK3']",0.8074383819439843,0,0,7
119,Senescence and Autophagy in Cancer WP615,0.2177306919637779,1.3998259930397217,2.1340296000037426,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'CDKN1B', 'FN1', 'HMGA1', 'GABARAP']",0.8074383819439843,0,0,9
120,TNF-alpha signaling pathway WP231,0.22742981531879544,1.382017812358064,2.046648963096223,"['HSP90AA1', 'JUN', 'BAD', 'RFK', 'CCL2', 'NFKBIE', 'SELE', 'SKP1', 'MAPK3']",0.8074383819439843,0,0,9
121,Prader-Willi and Angelman Syndrome WP3998,0.22778380441503848,1.5158560311284046,2.242494240861808,"['POMC', 'PCSK1', 'NDN', 'GHRL', 'CGA', 'TYR']",0.8074383819439843,0,0,6
122,IL-3 signaling pathway WP286,0.22828518192352404,1.59542031595318,2.3566904895325256,"['JUN', 'YWHAB', 'BAD', 'FOS', 'MAPK3']",0.8074383819439843,0,0,5
123,Netrin-UNC5B signaling pathway WP4747,0.22828518192352404,1.59542031595318,2.3566904895325256,"['JUN', 'CCL2', 'NTN1', 'SELE', 'MAPK3']",0.8074383819439843,0,0,5
124,Peptide GPCRs WP24,0.22828518192352404,1.59542031595318,2.3566904895325256,"['MC4R', 'GNRHR', 'SSTR1', 'SSTR3', 'HCRTR1']",0.8074383819439843,0,0,5
125,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.22828518192352404,1.59542031595318,2.3566904895325256,"['CDKN1A', 'HSP90AA1', 'JUN', 'FOS', 'ELK1']",0.8074383819439843,0,0,5
126,Iron metabolism in placenta WP2007,0.2317047703585335,2.4237393328161367,3.5442128410591374,"['HEPHL1', 'FTH1']",0.8074383819439843,0,0,2
127,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.2317047703585335,2.4237393328161367,3.5442128410591374,"['JUN', 'MAPK3']",0.8074383819439843,0,0,2
128,Serotonin and anxiety-related events WP3944,0.2317047703585335,2.4237393328161367,3.5442128410591374,"['CRH', 'FOS']",0.8074383819439843,0,0,2
129,Estrogen signaling pathway WP712,0.23342882887605085,1.9138607388035305,2.784433979109856,"['JUN', 'FOS', 'ELK1']",0.8074383819439843,0,0,3
130,Unfolded protein response WP4925,0.23342882887605085,1.9138607388035305,2.784433979109856,"['XBP1', 'HSPA5', 'DDIT3']",0.8074383819439843,0,0,3
131,Nuclear Receptors Meta-Pathway WP2882,0.23639047109582834,1.2033238912671538,1.7355183128509293,"['EGR1', 'JUN', 'HSP90AA1', 'CDKN1B', 'HSP90AB1', 'GADD45B', 'SRXN1', 'GPX3', 'TSC22D3', 'GSTP1', 'AIP', 'SLC5A3', 'DNAJB1', 'RGS2', 'CYP2A6', 'FTH1', 'PRDX1', 'B3GNT5', 'ENC1', 'BHLHE40', 'HMOX1', 'CCL2']",0.8074383819439843,0,0,22
132,miRNA regulation of DNA damage response WP1530,0.23684859203690206,1.4388827287607582,2.0724719956275255,"['CDKN1A', 'CDKN1B', 'GADD45B', 'CDK5', 'GADD45A', 'H2AFX', 'CYCS']",0.8074383819439843,0,0,7
133,Complement and Coagulation Cascades WP558,0.24273680305454784,1.5544124097778842,2.2007021739867882,"['SERPIND1', 'F12', 'MASP2', 'PLG', 'CLU']",0.8167945053443366,0,0,5
134,Cell cycle WP179,0.24322325270253578,1.3083563112745098,1.8497221269593134,"['CDKN2D', 'CDKN1A', 'CDKN1B', 'PTTG1', 'GADD45B', 'GADD45A', 'YWHAB', 'YWHAG', 'SKP1', 'ANAPC11', 'YWHAH']",0.8167945053443366,0,0,11
135,Small cell lung cancer WP4658,0.25743648471315683,1.331199345534797,1.8064138839175345,"['CDKN1A', 'CDKN1B', 'LAMB3', 'GADD45B', 'GADD45A', 'CKS2', 'FN1', 'CYCS', 'SKP1']",0.8326254727967329,0,0,9
136,Signaling of Hepatocyte Growth Factor Receptor WP313,0.25885774736448997,1.6162652162652162,2.1843446291066626,"['JUN', 'FOS', 'ELK1', 'MAPK3']",0.8326254727967329,0,0,4
137,Development and heterogeneity of the ILC family WP3893,0.260889314809643,2.2032583397982934,2.960427991886581,"['IL7', 'IL18']",0.8326254727967329,0,0,2
138,Glutathione metabolism WP100,0.260889314809643,2.2032583397982934,2.960427991886581,"['GPX4', 'GPX3']",0.8326254727967329,0,0,2
139,Major receptors targeted by epinephrine and norepinephrine WP4589,0.260889314809643,2.2032583397982934,2.960427991886581,"['ADCY10', 'ADRA1D']",0.8326254727967329,0,0,2
140,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.260889314809643,2.2032583397982934,2.960427991886581,"['PTTG1', 'ANAPC11']",0.8326254727967329,0,0,2
141,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.260889314809643,2.2032583397982934,2.960427991886581,"['JUN', 'TLR9']",0.8326254727967329,0,0,2
142,3q29 copy number variation syndrome WP4906,0.2667207611001495,1.4264133669031815,1.8850808734412334,"['TM4SF19', 'JUN', 'DYNLT3', 'DYNLRB1', 'DYNLL1', 'DYNLL2']",0.8414102576355582,0,0,6
143,Hepatitis B infection WP4666,0.2707073820946825,1.254886630179828,1.6397814572408198,"['CREB3', 'JUN', 'EGR2', 'CDKN1A', 'EGR3', 'ATP6AP1', 'YWHAB', 'BAD', 'CYCS', 'FOS', 'ELK1', 'MAPK3']",0.8414102576355582,0,0,12
144,Gastric acid production WP2596,0.27200594420758895,4.0382428940568476,5.257515059922189,['CCK'],0.8414102576355582,0,0,1
145,Steroid Biosynthesis WP496,0.27200594420758895,4.0382428940568476,5.257515059922189,['HSD3B1'],0.8414102576355582,0,0,1
146,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.2761881539575485,1.5640273704789833,2.0123916767016787,"['JUN', 'DDIT3', 'FOS', 'MAPK3']",0.8414102576355582,0,0,4
147,Gastrin signaling pathway WP4659,0.2792217853852893,1.2766342084719997,1.6286646657815773,"['EGR1', 'JUN', 'CDKN1A', 'PRKCH', 'CDKN1B', 'BAD', 'FOS', 'ELK1', 'RHOB', 'MAPK3']",0.8414102576355582,0,0,10
148,"GPCRs, Other WP117",0.28005966407583427,1.3988925471415743,1.7804441440194902,"['GPR132', 'GPR183', 'GNRHR', 'ADRA1D', 'OR10A2', 'GPR18']",0.8414102576355582,0,0,6
149,Pyrimidine metabolism WP4022,0.2872598632180145,1.3108634745423522,1.6351291847782505,"['POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.8414102576355582,0,0,8
150,Vitamin D Receptor Pathway WP2877,0.2889784372802276,1.2468165887850466,1.5478021095399546,"['CDKN2D', 'SULT1C2', 'COLEC11', 'CDKN1A', 'CEACAM1', 'CDKN1B', 'COL13A1', 'GADD45A', 'S100A6', 'TIMP2', 'LGALS9']",0.8414102576355582,0,0,11
151,Airway smooth muscle cell contraction WP4962,0.29009572286901997,2.0195241789500904,2.4992507002029036,"['CALM1', 'CALM2']",0.8414102576355582,0,0,2
152,Fatty acid transporters WP5061,0.29009572286901997,2.0195241789500904,2.4992507002029036,"['FABP7', 'ACSBG2']",0.8414102576355582,0,0,2
153,Leptin Insulin Overlap WP3935,0.29009572286901997,2.0195241789500904,2.4992507002029036,"['SOCS3', 'LEPR']",0.8414102576355582,0,0,2
154,Phytochemical activity on NRF2 transcriptional activation WP3,0.29009572286901997,2.0195241789500904,2.4992507002029036,"['CEBPB', 'HMOX1']",0.8414102576355582,0,0,2
155,Striated Muscle Contraction Pathway WP383,0.2970469271729196,1.6525621118012421,2.0059875535966425,"['MYOM1', 'ACTC1', 'ACTG1']",0.8414102576355582,0,0,3
156,Cytosolic DNA-sensing pathway WP4655,0.3025899237994127,1.4094542298093964,1.6848288544577337,"['IL18', 'ISG15', 'POLR3K', 'POLR2K', 'POLR2L']",0.8414102576355582,0,0,5
157,Synaptic Vesicle Pathway WP2267,0.3025899237994127,1.4094542298093964,1.6848288544577337,"['RAB3A', 'AP2S1', 'SLC25A4', 'SLC18A2', 'AP2M1']",0.8414102576355582,0,0,5
158,IL-5 signaling pathway WP127,0.3113451243461444,1.469049469049469,1.7141651583984183,"['JUN', 'FOS', 'ELK1', 'MAPK3']",0.8414102576355582,0,0,4
159,Oxidation by Cytochrome P450 WP43,0.3113451243461444,1.469049469049469,1.7141651583984183,"['CYP39A1', 'CYP26B1', 'CYP2A6', 'CYP2C18']",0.8414102576355582,0,0,4
160,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.3113451243461444,1.469049469049469,1.7141651583984183,"['JUN', 'CCL2', 'RELB', 'MAPK3']",0.8414102576355582,0,0,4
161,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.31792011181497415,1.3773328149300155,1.5783616304268262,"['JUN', 'FOS', 'CALM1', 'CALM2', 'MAPK3']",0.8414102576355582,0,0,5
162,16p11.2 distal deletion syndrome WP4950,0.3185328230141187,1.5806103159600324,1.8082652313965262,"['PLN', 'SLN', 'CD81']",0.8414102576355582,0,0,3
163,White fat cell differentiation WP4149,0.3185328230141187,1.5806103159600324,1.8082652313965262,"['CEBPB', 'EGR2', 'DDIT3']",0.8414102576355582,0,0,3
164,Hypertrophy Model WP516,0.31915092022433694,1.8640568120785344,2.128922851408836,"['IL18', 'ATF3']",0.8414102576355582,0,0,2
165,Overview of nanoparticle effects WP3287,0.31915092022433694,1.8640568120785344,2.128922851408836,"['FN1', 'HMOX1']",0.8414102576355582,0,0,2
166,TP53 network WP1742,0.31915092022433694,1.8640568120785344,2.128922851408836,"['CDKN1A', 'GADD45A']",0.8414102576355582,0,0,2
167,Tryptophan catabolism leading to NAD+ production WP4210,0.31915092022433694,1.8640568120785344,2.128922851408836,"['HAAO', 'KMO']",0.8414102576355582,0,0,2
168,Leptin signaling pathway WP2034,0.32185296215666176,1.2856957424714435,1.4575424486796065,"['SOCS3', 'CISH', 'BAD', 'CFL2', 'LEPR', 'ELK1', 'MAPK3']",0.8414102576355582,0,0,7
169,Composition of Lipid Particles WP3601,0.32755855051923743,3.0284883720930234,3.3800609223520297,['LPL'],0.8414102576355582,0,0,1
170,let-7 inhibition of ES cell reprogramming WP3299,0.32755855051923743,3.0284883720930234,3.3800609223520297,['EGR1'],0.8414102576355582,0,0,1
171,miR-517 relationship with ARCN1 and USP1 WP3596,0.32755855051923743,3.0284883720930234,3.3800609223520297,['CDKN1A'],0.8414102576355582,0,0,1
172,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.32755855051923743,3.0284883720930234,3.3800609223520297,['MAS1'],0.8414102576355582,0,0,1
173,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.32755855051923743,3.0284883720930234,3.3800609223520297,['MAPK3'],0.8414102576355582,0,0,1
174,ATM Signaling Pathway WP2516,0.32908490076412944,1.425750719868367,1.5846356735938414,"['CDKN1A', 'JUN', 'GADD45A', 'H2AFX']",0.8414102576355582,0,0,4
175,Hematopoietic Stem Cell Differentiation WP2849,0.32908490076412944,1.425750719868367,1.5846356735938414,"['TPO', 'TRAF3IP3', 'FOS', 'RUNX1']",0.8414102576355582,0,0,4
176,Lung fibrosis WP3624,0.32908490076412944,1.425750719868367,1.5846356735938414,"['CEBPB', 'HMOX1', 'CCL2', 'FGF1']",0.8414102576355582,0,0,4
177,Glycogen Synthesis and Degradation WP500,0.34687709172828,1.384926184926185,1.466338744268842,"['CALM3', 'CALM1', 'CALM2', 'HK2']",0.8769364678523933,0,0,4
178,PDGF Pathway WP2526,0.34687709172828,1.384926184926185,1.466338744268842,"['JUN', 'FOS', 'ELK1', 'MAPK3']",0.8769364678523933,0,0,4
179,Endothelin Pathways WP2197,0.3614866364288017,1.453975155279503,1.4794636379161235,"['ADCY10', 'CALM1', 'CALM2']",0.9066962148848815,0,0,3
180,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.3762436093503768,1.6153090250840445,1.5789943715290067,"['JUN', 'MAPK3']",0.9066962148848815,0,0,2
181,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.3762436093503768,1.6153090250840445,1.5789943715290067,"['EIF1AX', 'EIF1']",0.9066962148848815,0,0,2
182,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.3762436093503768,1.6153090250840445,1.5789943715290067,"['FN1', 'MAPK3']",0.9066962148848815,0,0,2
183,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.37887501144586405,2.4226356589147287,2.3512864063093377,['CYP2C18'],0.9066962148848815,0,0,1
184,Fatty Acid Omega Oxidation WP206,0.37887501144586405,2.4226356589147287,2.3512864063093377,['CYP2A6'],0.9066962148848815,0,0,1
185,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.37887501144586405,2.4226356589147287,2.3512864063093377,['CDKN1A'],0.9066962148848815,0,0,1
186,miRNA Biogenesis WP2338,0.37887501144586405,2.4226356589147287,2.3512864063093377,['RAN'],0.9066962148848815,0,0,1
187,Peroxiredoxin 2 induced ovarian failure WP4873,0.37887501144586405,2.4226356589147287,2.3512864063093377,['PRDX2'],0.9066962148848815,0,0,1
188,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.3808789780427001,1.1363614151681,1.0968996709922123,"['SHC4', 'NTRK1', 'EGR1', 'JUN', 'EGR2', 'RAB3A', 'CDK5', 'BAD', 'CFL1', 'FOS', 'ELK1', 'MAPK3']",0.9066962148848815,0,0,12
189,IL-6 signaling pathway WP364,0.3824643981263342,1.30989730989731,1.2589681184807855,"['SOCS3', 'BAD', 'MAPK3', 'NR2F6']",0.9066962148848815,0,0,4
190,Heart Development WP1591,0.3828272907291722,1.3979634495938844,1.3422844240568559,"['HEY1', 'BHLHE40', 'FGF10']",0.9066962148848815,0,0,3
191,Eukaryotic Transcription Initiation WP405,0.4001872873921355,1.2753445385024333,1.1679893804467179,"['TAF13', 'POLR2I', 'POLR3K', 'POLR2K']",0.9372398288076489,0,0,4
192,GABA receptor Signaling WP4159,0.4040010980029563,1.3461007591442373,1.2200218433906003,"['GABRQ', 'AP2S1', 'AP2M1']",0.9372398288076489,0,0,3
193,Nanomaterial induced apoptosis WP2507,0.40405450397485304,1.514255236617533,1.3722264227541996,"['ENDOG', 'CYCS']",0.9372398288076489,0,0,2
194,Nicotine Activity on Dopaminergic Neurons WP1602,0.40405450397485304,1.514255236617533,1.3722264227541996,"['CDK5', 'SLC18A2']",0.9372398288076489,0,0,2
195,Regulation of Microtubule Cytoskeleton WP2038,0.4178182670246103,1.2425637041021655,1.08439616590821,"['PARD6A', 'CFL2', 'STMN1', 'RHO']",0.9639454990551853,0,0,4
196,"Cerebral organic acidurias, including diseases WP4519",0.4262781206932931,2.018733850129199,1.7213002266220652,['MDH2'],0.9639454990551853,0,0,1
197,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.4262781206932931,2.018733850129199,1.7213002266220652,['DHCR24'],0.9639454990551853,0,0,1
198,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4262781206932931,2.018733850129199,1.7213002266220652,['HEY1'],0.9639454990551853,0,0,1
199,Tgif disruption of Shh signaling WP3674,0.4262781206932931,2.018733850129199,1.7213002266220652,['NODAL'],0.9639454990551853,0,0,1
200,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.435326407370869,1.2114219114219114,1.007490138346811,"['ADCY10', 'CFL1', 'BANF1', 'MAPK3']",0.9652583842883451,0,0,4
201,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.435326407370869,1.2114219114219114,1.007490138346811,"['LAG3', 'CXCL17', 'CCL2', 'CXCL5']",0.9652583842883451,0,0,4
202,MET in type 1 papillary renal cell carcinoma WP4205,0.44165134895039004,1.1648373011125732,0.9519452426970858,"['CDKN1A', 'JUN', 'BAD', 'RPL11', 'MAPK3']",0.9652583842883451,0,0,5
203,Notch Signaling Pathway Netpath WP61,0.44165134895039004,1.1648373011125732,0.9519452426970858,"['PSENEN', 'CDKN1A', 'HEY1', 'SKP1', 'DLL3']",0.9652583842883451,0,0,5
204,miRNA regulation of prostate cancer signaling pathways WP3981,0.4456509934399755,1.2531055900621118,1.0127839464071617,"['CDKN1A', 'CDKN1B', 'BAD']",0.9652583842883451,0,0,3
205,Non-small cell lung cancer WP4255,0.44594481727321855,1.1357247081712063,0.9171659165451965,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'CYCS', 'MAPK3']",0.9652583842883451,0,0,6
206,Ras signaling WP4223,0.44861561353282664,1.0714658320292123,0.8588750667676155,"['SHC4', 'NTRK1', 'PLA2G2C', 'BAD', 'ELK1', 'GNG3', 'GNG8', 'CALM3', 'CALM1', 'FGFR4', 'CALM2', 'ARF6', 'MAPK3']",0.9652583842883451,0,0,13
207,Globo Sphingolipid Metabolism WP1424,0.45777888250916,1.3458322558400138,1.0515916048952823,"['ST6GALNAC1', 'FUT1']",0.9652583842883451,0,0,2
208,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.45777888250916,1.3458322558400138,1.0515916048952823,"['SELE', 'RELB']",0.9652583842883451,0,0,2
209,Purine metabolism and related disorders WP4224,0.45777888250916,1.3458322558400138,1.0515916048952823,"['PRPS1', 'APRT']",0.9652583842883451,0,0,2
210,MAPK Cascade WP422,0.46604078687791683,1.2112577639751554,0.924773649379246,"['JUN', 'ELK1', 'MAPK3']",0.9652583842883451,0,0,3
211,Melatonin metabolism and effects WP3298,0.46604078687791683,1.2112577639751554,0.924773649379246,"['PER2', 'CALM1', 'CALM2']",0.9652583842883451,0,0,3
212,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.46604078687791683,1.2112577639751554,0.924773649379246,"['LDHA', 'PKM', 'PGK1']",0.9652583842883451,0,0,3
213,Canonical NF-KB pathway WP4562,0.47006609304720565,1.7302325581395348,1.3061213631882889,['NFKBIE'],0.9652583842883451,0,0,1
214,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.47006609304720565,1.7302325581395348,1.3061213631882889,['ELOB'],0.9652583842883451,0,0,1
215,Macrophage markers WP4146,0.47006609304720565,1.7302325581395348,1.3061213631882889,['CD68'],0.9652583842883451,0,0,1
216,Methylation Pathways WP704,0.47006609304720565,1.7302325581395348,1.3061213631882889,['MAT2B'],0.9652583842883451,0,0,1
217,Mitochondrial CII Assembly WP4920,0.47006609304720565,1.7302325581395348,1.3061213631882889,['SDHAF1'],0.9652583842883451,0,0,1
218,Differentiation of white and brown adipocyte WP2895,0.4835686341836411,1.274917316565269,0.9263065025817602,"['CEBPB', 'EBF3']",0.9652583842883451,0,0,2
219,Pregnane X receptor pathway WP2876,0.4835686341836411,1.274917316565269,0.9263065025817602,"['HSP90AA1', 'CYP2A6']",0.9652583842883451,0,0,2
220,Regulation of Actin Cytoskeleton WP51,0.48555496731792047,1.0491141732283464,0.757945941816203,"['CFL2', 'TMSB4X', 'CFL1', 'FN1', 'BRK1', 'FGF1', 'FGFR4', 'ACTB', 'ACTG1', 'FGF10', 'MAPK3']",0.9652583842883451,0,0,11
221,p38 MAPK Signaling Pathway WP400,0.48609074943375785,1.1721097976357444,0.8455130594882452,"['DDIT3', 'HSPB1', 'ELK1']",0.9652583842883451,0,0,3
222,Parkinson's disease pathway WP2371,0.48609074943375785,1.1721097976357444,0.8455130594882452,"['PINK1', 'UBB', 'CYCS']",0.9652583842883451,0,0,3
223,Pancreatic adenocarcinoma pathway WP4263,0.48674485830299885,1.07322843960724,0.7727407875585781,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'PEBP1', 'DUSP6', 'MAPK3']",0.9652583842883451,0,0,7
224,p53 transcriptional gene network WP4963,0.48700869999998936,1.1010886469673407,0.7922038731579902,"['CDKN1A', 'GADD45A', 'CCL2', 'ISG15', 'RPRM']",0.9652583842883451,0,0,5
225,ErbB signaling pathway WP673,0.49914764295465663,1.0597449376947041,0.7363673193917658,"['SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'BAD', 'ELK1', 'MAPK3']",0.9652583842883451,0,0,7
226,G1 to S cell cycle control WP45,0.5018423040961976,1.0813569206842923,0.74556244663432,"['CDKN2D', 'CREB3', 'CDKN1A', 'CDKN1B', 'GADD45A']",0.9652583842883451,0,0,5
227,Constitutive Androstane Receptor Pathway WP2875,0.5085826020272097,1.2110938712179984,0.8188540338856349,"['HSP90AA1', 'CYP2A6']",0.9652583842883451,0,0,2
228,NRF2-ARE regulation WP4357,0.5085826020272097,1.2110938712179984,0.8188540338856349,"['CEBPB', 'HMOX1']",0.9652583842883451,0,0,2
229,Estrogen Receptor Pathway WP2881,0.510514434356947,1.5138565891472868,1.0178208390595316,['JUN'],0.9652583842883451,0,0,1
230,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.510514434356947,1.5138565891472868,1.0178208390595316,['CEBPB'],0.9652583842883451,0,0,1
231,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.510514434356947,1.5138565891472868,1.0178208390595316,['HMOX1'],0.9652583842883451,0,0,1
232,Leptin and adiponectin WP3934,0.510514434356947,1.5138565891472868,1.0178208390595316,['LEPR'],0.9652583842883451,0,0,1
233,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.510514434356947,1.5138565891472868,1.0178208390595316,['SOCS3'],0.9652583842883451,0,0,1
234,PTF1A related regulatory pathway WP4147,0.510514434356947,1.5138565891472868,1.0178208390595316,['FGF10'],0.9652583842883451,0,0,1
235,Role of Osx and miRNAs in tooth development WP3971,0.510514434356947,1.5138565891472868,1.0178208390595316,['DKK1'],0.9652583842883451,0,0,1
236,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.510514434356947,1.5138565891472868,1.0178208390595316,['DLL3'],0.9652583842883451,0,0,1
237,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.510514434356947,1.5138565891472868,1.0178208390595316,['ELK1'],0.9652583842883451,0,0,1
238,Tamoxifen metabolism WP691,0.510514434356947,1.5138565891472868,1.0178208390595316,['CYP2A6'],0.9652583842883451,0,0,1
239,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5250482287579774,1.1009316770186335,0.7092919189797968,"['PRKCH', 'HSD3B1', 'MAPK3']",0.988584531134267,0,0,3
240,Osteoblast differentiation WP4787,0.53224882230531,1.019715305410838,0.6430775306527139,"['FZD1', 'PRKCH', 'HEY1', 'FGF1', 'FGFR4', 'FGF10', 'DLL3', 'MAPK3']",0.9907233270888978,0,0,8
241,EPO Receptor Signaling WP581,0.5327889892344739,1.1533488492371347,0.7261828350556956,"['CISH', 'MAPK3']",0.9907233270888978,0,0,2
242,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5327889892344739,1.1533488492371347,0.7261828350556956,"['CGA', 'MAPK3']",0.9907233270888978,0,0,2
243,Vitamin D-sensitive calcium signaling in depression WP4698,0.5439043742568389,1.0684828279137741,0.6506866280736565,"['TPH1', 'CALB1', 'GPX4']",0.9931524211969353,0,0,3
244,Cytokines and Inflammatory Response WP530,0.5478776695361987,1.3455641688199829,0.8096303304043063,['IL7'],0.9931524211969353,0,0,1
245,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.5478776695361987,1.3455641688199829,0.8096303304043063,['FN1'],0.9931524211969353,0,0,1
246,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5478776695361987,1.3455641688199829,0.8096303304043063,['MAT2B'],0.9931524211969353,0,0,1
247,Trans-sulfuration pathway WP2333,0.5478776695361987,1.3455641688199829,0.8096303304043063,['MAT2B'],0.9931524211969353,0,0,1
248,Valproic acid pathway WP3871,0.5478776695361987,1.3455641688199829,0.8096303304043063,['CYP2A6'],0.9931524211969353,0,0,1
249,RANKL/RANK signaling pathway WP2018,0.5522862304155525,1.030534477342988,0.611816811977983,"['JUN', 'FOS', 'RELB', 'MAPK3']",0.9931524211969353,0,0,4
250,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.552845147721301,1.0090142671854734,0.5980198907645496,"['FZD1', 'JUN', 'FRAT2', 'NOTUM', 'DKK1', 'ATF3']",0.9931524211969353,0,0,6
251,Canonical and non-canonical Notch signaling WP3845,0.5561653558702837,1.1008533747090767,0.6458592550219799,"['HEY1', 'DLL3']",0.9931524211969353,0,0,2
252,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.5561653558702837,1.1008533747090767,0.6458592550219799,"['CALM1', 'CALM2']",0.9931524211969353,0,0,2
253,Prostaglandin Synthesis and Regulation WP98,0.5623174607721927,1.037888198757764,0.59750052008593,"['HSD11B1', 'HSD11B2', 'S100A6']",0.9962317218404988,0,0,3
254,Vitamin B12 metabolism WP1533,0.5623174607721927,1.037888198757764,0.59750052008593,"['CCL2', 'PLG', 'SOD1']",0.9962317218404988,0,0,3
255,Amino Acid metabolism WP3925,0.5655634468228151,0.9951281914610095,0.5671561902950875,"['AOC3', 'TPH1', 'TPO', 'LDHA', 'PKM', 'MDH2']",0.9964863981623118,0,0,6
256,Acute viral myocarditis WP4298,0.5731896932651189,0.9924024169492389,0.5523102162718606,"['ENDOG', 'CYCS', 'ACTB', 'EIF4G2', 'MAPK3']",0.9964863981623118,0,0,5
257,Cannabinoid receptor signaling WP3869,0.5786973780762188,1.052922724053024,0.575923039928021,"['PRKAR1A', 'MAPK3']",0.9964863981623118,0,0,2
258,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.5802708132314156,1.0089932712215322,0.5491550461281147,"['CISH', 'RELB', 'MAPK3']",0.9964863981623118,0,0,3
259,Biogenic Amine Synthesis WP550,0.5823909393704177,1.2109302325581395,0.654645037070531,['TPH1'],0.9964863981623118,0,0,1
260,Cells and molecules involved in local acute inflammatory response  WP4493,0.5823909393704177,1.2109302325581395,0.654645037070531,['SELP'],0.9964863981623118,0,0,1
261,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.5823909393704177,1.2109302325581395,0.654645037070531,['TPO'],0.9964863981623118,0,0,1
262,Osteopontin Signaling WP1434,0.5823909393704177,1.2109302325581395,0.654645037070531,['MAPK3'],0.9964863981623118,0,0,1
263,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.5823909393704177,1.2109302325581395,0.654645037070531,['IGLL1'],0.9964863981623118,0,0,1
264,16p11.2 proximal deletion syndrome WP4949,0.6001879106036797,0.9607741489545533,0.490487201629389,"['ALDOA', 'SEZ6L2', 'CCT7', 'YPEL3', 'MAPK3']",0.9994944828815825,0,0,5
265,7-oxo-C and 7beta-HC pathways WP5064,0.6003777419200561,1.0089862942849754,0.5147810256587203,"['HSD11B1', 'HSD11B2']",0.9994944828815825,0,0,2
266,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.6003777419200561,1.0089862942849754,0.5147810256587203,"['CDKN1A', 'MAPK3']",0.9994944828815825,0,0,2
267,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6003777419200561,1.0089862942849754,0.5147810256587203,"['CEBPB', 'GAL']",0.9994944828815825,0,0,2
268,Toll-like Receptor Signaling related to MyD88 WP3858,0.6003777419200561,1.0089862942849754,0.5147810256587203,"['TLR9', 'RELB']",0.9994944828815825,0,0,2
269,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.614271475444415,1.1007751937984496,0.5364279028756769,['DKK1'],0.9994944828815825,0,0,1
270,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.614271475444415,1.1007751937984496,0.5364279028756769,['LPL'],0.9994944828815825,0,0,1
271,Osteoclast Signaling WP12,0.614271475444415,1.1007751937984496,0.5364279028756769,['ATP6V1G1'],0.9994944828815825,0,0,1
272,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6147472160391978,0.9557657731284733,0.46502222322779707,"['CDKN1A', 'JUN', 'MAPK3']",0.9994944828815825,0,0,3
273,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6147472160391978,0.9557657731284733,0.46502222322779707,"['ACTC1', 'ACTB', 'ACTG1']",0.9994944828815825,0,0,3
274,22q11.2 copy number variation syndrome WP4657,0.6164112128380453,0.9413897542402215,0.45548294582371424,"['CYP26B1', 'MRPL40', 'ACTC1', 'SERPIND1', 'HIST1H4C', 'RAN', 'FGF10']",0.9994944828815825,0,0,7
275,IL17 signaling pathway WP2112,0.6212051588351565,0.9685647788983708,0.461127766632885,"['CEBPB', 'MAPK3']",0.9994944828815825,0,0,2
276,Monoamine GPCRs WP58,0.6212051588351565,0.9685647788983708,0.461127766632885,"['HTR2B', 'ADRA1D']",0.9994944828815825,0,0,2
277,Type II interferon signaling (IFNG) WP619,0.6212051588351565,0.9685647788983708,0.461127766632885,"['SOCS3', 'ISG15']",0.9994944828815825,0,0,2
278,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.6261932434533509,0.9310922359133867,0.4358407932588918,"['FZD1', 'JUN', 'FRAT2', 'NOTUM', 'DKK1']",0.9994944828815825,0,0,5
279,TGF-beta Signaling Pathway WP366,0.6304371401881675,0.9308772350894036,0.429452604256507,"['JUN', 'CDKN1A', 'PARD6A', 'CITED1', 'FN1', 'NEDD9', 'FOS', 'ATF3', 'SKP1']",0.9994944828815825,0,0,9
280,Integrated Cancer Pathway WP1971,0.631251813031249,0.9311992355470616,0.42839860525384355,"['CDKN1A', 'CDKN1B', 'BAD']",0.9994944828815825,0,0,3
281,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6411834898346509,0.9312526108491973,0.41388554478631057,"['FZD1', 'FGF1']",0.9994944828815825,0,0,2
282,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.6411834898346509,0.9312526108491973,0.41388554478631057,"['FZD1', 'ADAMTS2']",0.9994944828815825,0,0,2
283,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6437199632979999,1.0089793281653747,0.4444468046635692,['CCK'],0.9994944828815825,0,0,1
284,Ganglio Sphingolipid Metabolism WP1423,0.6437199632979999,1.0089793281653747,0.4444468046635692,['FUT1'],0.9994944828815825,0,0,1
285,IL-9 signaling pathway WP22,0.6437199632979999,1.0089793281653747,0.4444468046635692,['MAPK3'],0.9994944828815825,0,0,1
286,TGF-beta Receptor Signaling WP560,0.6472593157277389,0.9078610248447205,0.39492705170526354,"['JUN', 'FOS', 'MAPK3']",0.9994944828815825,0,0,3
287,AGE/RAGE pathway WP2324,0.6550853204823299,0.8965437854326743,0.3792288689170961,"['JUN', 'CYCS', 'MAPK3', 'SOD1']",0.9994944828815825,0,0,4
288,ESC Pluripotency Pathways WP3931,0.6589006749830759,0.9010986279578445,0.3759225573208929,"['FZD1', 'JUN', 'FOS', 'FGF1', 'FGFR4', 'ELK1', 'FGF10']",0.9994944828815825,0,0,7
289,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6603209687697709,0.8967043070999626,0.37215851233267866,"['CDKN1B', 'BAD']",0.9994944828815825,0,0,2
290,G Protein Signaling Pathways WP35,0.6603639001452063,0.8963827640870442,0.37196678532268024,"['GNG3', 'PRKCH', 'PRKAR1A', 'GNG8', 'CALM1', 'CALM2']",0.9994944828815825,0,0,6
291,ATM Signaling Network in Development and Disease  WP3878,0.6627665880794249,0.8856612634449326,0.3643011774733733,"['CDK5', 'H2AFX', 'HSPB1']",0.9994944828815825,0,0,3
292,Cysteine and methionine catabolism WP4504,0.6709218017324615,0.9313059033989266,0.37168669004288807,['SQOR'],0.9994944828815825,0,0,1
293,ID signaling pathway WP53,0.6709218017324615,0.9313059033989266,0.37168669004288807,['ELK1'],0.9994944828815825,0,0,1
294,miR-509-3p alteration of YAP1/ECM axis WP3967,0.6709218017324615,0.9313059033989266,0.37168669004288807,['FN1'],0.9994944828815825,0,0,1
295,Riboflavin and CoQ disorders WP5037,0.6709218017324615,0.9313059033989266,0.37168669004288807,['RFK'],0.9994944828815825,0,0,1
296,Base Excision Repair WP4752,0.6786295132194518,0.8646237393328161,0.33519727613910577,"['FEN1', 'POLE3']",0.9994944828815825,0,0,2
297,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6786295132194518,0.8646237393328161,0.33519727613910577,"['CCL2', 'PLG']",0.9994944828815825,0,0,2
298,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6922779934773332,0.8443593817709085,0.3105280903763496,"['XBP1', 'HSPA5', 'DDIT3']",0.9994944828815825,0,0,3
299,Histone Modifications WP2369,0.6922779934773332,0.8443593817709085,0.3105280903763496,"['SET', 'HIST1H4C', 'HIST1H3E']",0.9994944828815825,0,0,3
300,One-carbon metabolism and related pathways WP3940,0.6922779934773332,0.8443593817709085,0.3105280903763496,"['GPX4', 'GPX3', 'SOD1']",0.9994944828815825,0,0,3
301,Biomarkers for pyrimidine metabolism disorders WP4584,0.6960482665378002,0.8647286821705427,0.3133225674892725,['CKB'],0.9994944828815825,0,0,1
302,Dopaminergic Neurogenesis WP2855,0.6960482665378002,0.8647286821705427,0.3133225674892725,['SLC18A2'],0.9994944828815825,0,0,1
303,ERK Pathway in Huntington's Disease WP3853,0.6960482665378002,0.8647286821705427,0.3133225674892725,['ELK1'],0.9994944828815825,0,0,1
304,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.6960482665378002,0.8647286821705427,0.3133225674892725,['FZD1'],0.9994944828815825,0,0,1
305,Type II diabetes mellitus WP1584,0.6960482665378002,0.8647286821705427,0.3133225674892725,['KCNJ11'],0.9994944828815825,0,0,1
306,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6961241155565391,0.834755624515128,0.3023712823695899,"['JUN', 'FOS']",0.9994944828815825,0,0,2
307,Neovascularisation processes WP4331,0.6961241155565391,0.834755624515128,0.3023712823695899,"['RELB', 'MAPK3']",0.9994944828815825,0,0,2
308,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.7062853746140245,0.8251164596273292,0.28692262280156466,"['FOS', 'ELK1', 'MAPK3']",0.9994944828815825,0,0,3
309,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7062853746140245,0.8251164596273292,0.28692262280156466,"['JUN', 'FOS', 'MAPK3']",0.9994944828815825,0,0,3
310,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7087507793527854,0.8401913772248142,0.28923699429596766,"['FZD1', 'CISH', 'CALM1', 'CALM2', 'MAPK3']",0.9994944828815825,0,0,5
311,Fatty acid beta-oxidation WP143,0.7128223052120956,0.8068787173519524,0.2731470935412227,"['TPI1', 'LPL']",0.9994944828815825,0,0,2
312,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7128223052120956,0.8068787173519524,0.2731470935412227,"['HEXIM1', 'SUPT4H1']",0.9994944828815825,0,0,2
313,Neural Crest Cell Migration during Development WP4564,0.7128223052120956,0.8068787173519524,0.2731470935412227,"['JUN', 'FOS']",0.9994944828815825,0,0,2
314,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7180689310348429,0.8203021084377017,0.27167561766444903,"['BAD', 'STMN1', 'FN1', 'MAPK3']",0.9994944828815825,0,0,4
315,Cancer immunotherapy by PD-1 blockade WP4585,0.7192575853496032,0.8070284237726099,0.26594470109170903,['JUN'],0.9994944828815825,0,0,1
316,NOTCH1 regulation of endothelial cell calcification WP3413,0.7192575853496032,0.8070284237726099,0.26594470109170903,['DLL3'],0.9994944828815825,0,0,1
317,Alpha 6 Beta 4 signaling pathway WP244,0.7287436746652259,0.7808003203283366,0.2470711603659942,"['LAMB3', 'MAPK3']",0.9994944828815825,0,0,2
318,Disruption of postsynaptic signaling by CNV WP4875,0.7287436746652259,0.7808003203283366,0.2470711603659942,"['YWHAG', 'MAPK3']",0.9994944828815825,0,0,2
319,Nuclear receptors WP170,0.7287436746652259,0.7808003203283366,0.2470711603659942,"['NR4A1', 'NR2F6']",0.9994944828815825,0,0,2
320,Type 2 papillary renal cell carcinoma WP4241,0.7287436746652259,0.7808003203283366,0.2470711603659942,"['CDKN1A', 'ELOB']",0.9994944828815825,0,0,2
321,Ciliary landscape WP4352,0.7384850787366839,0.8633516053249805,0.2617288223954461,"['DYNLT3', 'COPS7A', 'DYNLL1', 'COX6C', 'DYNLL2', 'LSM4', 'PSMD8', 'EXOSC4', 'ARHGDIA', 'NEFL', 'NEFM', 'DYNLRB1', 'CALM1', 'CALM2']",0.9994944828815825,0,0,14
322,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.7406959312988868,0.7565406976744186,0.2270871043566072,['MAPK3'],0.9994944828815825,0,0,1
323,Complement Activation WP545,0.7406959312988868,0.7565406976744186,0.2270871043566072,['MASP2'],0.9994944828815825,0,0,1
324,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.7406959312988868,0.7565406976744186,0.2270871043566072,['CDKN1A'],0.9994944828815825,0,0,1
325,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7515634619596226,0.7804596836854901,0.22289899400474336,"['SOCS3', 'DUSP2', 'STMN1', 'MAPK3']",0.9994944828815825,0,0,4
326,Ebola Virus Pathway on Host WP4217,0.7518257724453326,0.813930325904625,0.2321741687249897,"['SOCS3', 'ACTB', 'ACTG1', 'RHOB', 'HLA-DQB1', 'RELB', 'MAPK3']",0.9994944828815825,0,0,7
327,EGF/EGFR signaling pathway WP437,0.7534059724685558,0.8337236533957846,0.2360697332059748,"['NDUFA13', 'JUN', 'CFL1', 'STMN1', 'AP2S1', 'PEBP1', 'FOS', 'ELK1', 'AP2M1', 'ARF6']",0.9994944828815825,0,0,10
328,Neural Crest Cell Migration in Cancer WP4565,0.7583421928287585,0.7333850530126713,0.20286937928003296,"['JUN', 'FOS']",0.9994944828815825,0,0,2
329,Oxysterols derived from cholesterol WP4545,0.7583421928287585,0.7333850530126713,0.20286937928003296,"['CYP39A1', 'GPR183']",0.9994944828815825,0,0,2
330,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7593292652190771,0.7853810264385692,0.21623093230973658,"['MC4R', 'POMC', 'CREB3', 'TPO', 'BAD']",0.9994944828815825,0,0,5
331,15q13.3 copy number variation syndrome WP4942,0.7604983403504122,0.7119927040583676,0.194930323421667,['GOLGA8H'],0.9994944828815825,0,0,1
332,Apoptosis Modulation by HSP70 WP384,0.7604983403504122,0.7119927040583676,0.194930323421667,['CYCS'],0.9994944828815825,0,0,1
333,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7604983403504122,0.7119927040583676,0.194930323421667,['MAPK3'],0.9994944828815825,0,0,1
334,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.7604983403504122,0.7119927040583676,0.194930323421667,['CCL2'],0.9994944828815825,0,0,1
335,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7604983403504122,0.7119927040583676,0.194930323421667,['FN1'],0.9994944828815825,0,0,1
336,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.7604983403504122,0.7119927040583676,0.194930323421667,['MDH2'],0.9994944828815825,0,0,1
337,Transcription factor regulation in adipogenesis WP3599,0.7604983403504122,0.7119927040583676,0.194930323421667,['CEBPB'],0.9994944828815825,0,0,1
338,Cardiac Hypertrophic Response WP2795,0.769033887972463,0.7406832298136646,0.1945184096981887,"['CALM1', 'CALM2', 'MAPK3']",0.9994944828815825,0,0,3
339,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.769033887972463,0.7406832298136646,0.1945184096981887,"['CDKN1A', 'CEBPB', 'ACTB']",0.9994944828815825,0,0,3
340,Ebstein-Barr virus LMP1 signaling WP262,0.7787895594031438,0.6723944875107666,0.16810831214407654,['HSP90AA1'],0.9994944828815825,0,0,1
341,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7787895594031438,0.6723944875107666,0.16810831214407654,['LDHA'],0.9994944828815825,0,0,1
342,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7787895594031438,0.6723944875107666,0.16810831214407654,['BAD'],0.9994944828815825,0,0,1
343,Inflammatory Response Pathway WP453,0.7787895594031438,0.6723944875107666,0.16810831214407654,['FN1'],0.9994944828815825,0,0,1
344,miRNA targets in ECM and membrane receptors WP2911,0.7787895594031438,0.6723944875107666,0.16810831214407654,['FN1'],0.9994944828815825,0,0,1
345,RAS and bradykinin pathways in COVID-19 WP4969,0.7787895594031438,0.6723944875107666,0.16810831214407654,['F12'],0.9994944828815825,0,0,1
346,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7787895594031438,0.6723944875107666,0.16810831214407654,['NFKBIE'],0.9994944828815825,0,0,1
347,IL-1 signaling pathway WP195,0.780177872782857,0.7258229813664596,0.18017346528449218,"['JUN', 'CCL2', 'MAPK3']",0.9994944828815825,0,0,3
348,Modulators of TCR signaling and T cell activation WP5072,0.780177872782857,0.7258229813664596,0.18017346528449218,"['CDKN1B', 'NDUFB10', 'ELOB']",0.9994944828815825,0,0,3
349,PPAR signaling pathway WP3942,0.780177872782857,0.7258229813664596,0.18017346528449218,"['FABP7', 'LPL', 'ACSBG2']",0.9994944828815825,0,0,3
350,Apoptosis WP254,0.7819123475747912,0.7442950212180981,0.18310597731763337,"['JUN', 'BAD', 'CYCS', 'NFKBIE']",0.9994944828815825,0,0,4
351,Methionine De Novo and Salvage Pathway WP3580,0.7956848298313162,0.6369645042839658,0.14557958397580162,['MAT2B'],0.9994944828815825,0,0,1
352,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7956848298313162,0.6369645042839658,0.14557958397580162,['LDHA'],0.9994944828815825,0,0,1
353,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7956848298313162,0.6369645042839658,0.14557958397580162,['MAPK3'],0.9994944828815825,0,0,1
354,Triacylglyceride synthesis WP325,0.7956848298313162,0.6369645042839658,0.14557958397580162,['LPL'],0.9994944828815825,0,0,1
355,Urea cycle and metabolism of amino groups WP497,0.7956848298313162,0.6369645042839658,0.14557958397580162,['CKB'],0.9994944828815825,0,0,1
356,Vitamin D in inflammatory diseases WP4482,0.7956848298313162,0.6369645042839658,0.14557958397580162,['DUSP1'],0.9994944828815825,0,0,1
357,Endoderm differentiation WP2853,0.8051583650867399,0.7622575846874913,0.16519363889998784,"['DUSP4', 'DUSP2', 'TCEAL2', 'ONECUT1', 'DKK1', 'NODAL', 'NME1']",0.9994944828815825,0,0,7
358,Regulation of toll-like receptor signaling pathway WP1449,0.8071105170693901,0.7477556259777769,0.16024004664046088,"['JUN', 'CISH', 'PELI3', 'TLR9', 'FOS', 'MAPK3']",0.9994944828815825,0,0,6
359,Toll-like Receptor Signaling Pathway WP75,0.809239516683114,0.711321358380182,0.15055852100573938,"['JUN', 'TLR9', 'FOS', 'MAPK3']",0.9994944828815825,0,0,4
360,Kit receptor signaling pathway WP304,0.8109687129088257,0.6846068205789289,0.14344279452054615,"['BAD', 'FOS', 'MAPK3']",0.9994944828815825,0,0,3
361,Angiogenesis WP1539,0.8112906111057969,0.605077519379845,0.12653922768945894,['TIMP2'],0.9994944828815825,0,0,1
362,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8112906111057969,0.605077519379845,0.12653922768945894,['BCL2L14'],0.9994944828815825,0,0,1
363,Male infertility WP4673,0.8143523566931148,0.7400778210116732,0.15198396213710025,"['CYP26B1', 'MSH5', 'HMGA1', 'TEX15', 'CLU', 'ETV5']",0.9994944828815825,0,0,6
364,DNA Replication WP466,0.8203510655645905,0.6366828630925646,0.1260777879533547,"['UBC', 'UBA52']",0.9994944828815825,0,0,2
365,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.8257052496269557,0.5762273901808785,0.11035757721706964,['TRPA1'],0.9994944828815825,0,0,1
366,NAD+ biosynthetic pathways WP3645,0.8257052496269557,0.5762273901808785,0.11035757721706964,['ACMSD'],0.9994944828815825,0,0,1
367,Statin inhibition of cholesterol production WP430,0.8257052496269557,0.5762273901808785,0.11035757721706964,['LPL'],0.9994944828815825,0,0,1
368,Urea cycle and associated pathways WP4595,0.8257052496269557,0.5762273901808785,0.11035757721706964,['MDH2'],0.9994944828815825,0,0,1
369,DNA Mismatch Repair WP531,0.8390195964169525,0.55,0.09653666875275278,['POLE3'],0.9994944828815825,0,0,1
370,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.8390195964169525,0.55,0.09653666875275278,['MAPK3'],0.9994944828815825,0,0,1
371,Insulin Signaling WP481,0.8448048777288852,0.7445825230269485,0.1255735388826359,"['SOCS3', 'EGR1', 'XBP1', 'JUN', 'PRKCH', 'FOS', 'ELK1', 'ARF6', 'MAPK3']",0.9994944828815825,0,0,9
372,Interleukin-11 Signaling Pathway WP2332,0.8503217058187713,0.5899827811311472,0.09566011708796902,"['SOCS3', 'MAPK3']",0.9994944828815825,0,0,2
373,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.851317578118041,0.5260532524435456,0.08467881190254932,['HIST1H3E'],0.9994944828815825,0,0,1
374,Gastric Cancer Network 1 WP2361,0.851317578118041,0.5260532524435456,0.08467881190254932,['GATD3A'],0.9994944828815825,0,0,1
375,miRNAs involvement in the immune response in sepsis WP4329,0.851317578118041,0.5260532524435456,0.08467881190254932,['RELB'],0.9994944828815825,0,0,1
376,Signal Transduction of S1P Receptor WP26,0.851317578118041,0.5260532524435456,0.08467881190254932,['MAPK3'],0.9994944828815825,0,0,1
377,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.851317578118041,0.5260532524435456,0.08467881190254932,['TLR9'],0.9994944828815825,0,0,1
378,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.851317578118041,0.5260532524435456,0.08467881190254932,['DKK1'],0.9994944828815825,0,0,1
379,Nucleotide Excision Repair WP4753,0.859252881377296,0.5758986294284976,0.0873592205935861,"['CETN2', 'POLE3']",0.9994944828815825,0,0,2
380,Cell migration and invasion through p75NTR WP4561,0.8626767244100662,0.5041020671834625,0.07446356449193264,['JUN'],0.9994944828815825,0,0,1
381,MTHFR deficiency WP4288,0.8626767244100662,0.5041020671834625,0.07446356449193264,['CYCS'],0.9994944828815825,0,0,1
382,Integrated breast cancer pathway WP1984,0.8670969319036774,0.7104213470267297,0.10130928591754988,"['PLK3', 'JUN', 'GADD45A', 'BAD', 'RHO', 'PHB', 'FAU', 'JAKMIP1']",0.9994944828815825,0,0,8
383,SARS-CoV-2 mitochondrial interactions WP5038,0.8731686550358985,0.48390697674418603,0.06563063455647507,['PHB'],0.9994944828815825,0,0,1
384,Signal transduction through IL1R WP4496,0.8731686550358985,0.48390697674418603,0.06563063455647507,['JUN'],0.9994944828815825,0,0,1
385,Glioblastoma signaling pathways WP2261,0.874805604862354,0.6278166278166278,0.08397272354958644,"['CDKN1A', 'CDKN1B', 'PRKCH', 'MAPK3']",0.9994944828815825,0,0,4
386,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8756672318540164,0.5496508921644686,0.07297667214606987,"['EIF4A2', 'MAPK3']",0.9994944828815825,0,0,2
387,TYROBP causal network in microglia WP3945,0.8756672318540164,0.5496508921644686,0.07297667214606987,"['IL18', 'SAMSN1']",0.9994944828815825,0,0,2
388,Retinoblastoma gene in cancer WP2446,0.8807274544594851,0.6197278504970812,0.07870981241833618,"['CDKN1A', 'CDKN1B', 'H2AFZ', 'STMN1']",0.9994944828815825,0,0,4
389,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8822382331190849,0.5848903025445803,0.07328275067384513,"['CDKN1A', 'CDKN1B', 'DKK1']",0.9994944828815825,0,0,3
390,DNA damage response (only ATM dependent) WP710,0.8822983225888777,0.6426408788590715,0.08047473357541092,"['JUN', 'CDKN1A', 'CDKN1B', 'BIK', 'BAD']",0.9994944828815825,0,0,5
391,Gastric Cancer Network 2 WP2363,0.8828595301417136,0.4652653548002385,0.057967026033849324,['S100A6'],0.9994944828815825,0,0,1
392,Lipid Metabolism Pathway WP3965,0.8828595301417136,0.4652653548002385,0.057967026033849324,['PRKAR1A'],0.9994944828815825,0,0,1
393,Nanoparticle-mediated activation of receptor signaling WP2643,0.8828595301417136,0.4652653548002385,0.057967026033849324,['FN1'],0.9994944828815825,0,0,1
394,Resistin as a regulator of inflammation WP4481,0.8828595301417136,0.4652653548002385,0.057967026033849324,['MAPK3'],0.9994944828815825,0,0,1
395,PI3K-Akt signaling pathway WP4172,0.8869938547382041,0.7566812764321414,0.0907391187569047,"['NTRK1', 'CDKN1A', 'HSP90AA1', 'CDKN1B', 'HSP90AB1', 'LAMB3', 'BAD', 'FN1', 'FGF1', 'CREB3', 'GNG3', 'IL7', 'GNG8', 'FGFR4', 'FGF10', 'MAPK3']",0.9994944828815825,0,0,16
396,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.88704683602992,0.750692646886666,0.08997614041630074,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'HSP90AB1', 'LAMB3', 'BAD', 'FN1', 'FGF1', 'CREB3', 'GNG3', 'GNG8', 'FGFR4', 'PELO', 'FGF10', 'MAPK3']",0.9994944828815825,0,0,15
397,Wnt signaling WP428,0.8874685481918537,0.6358353114512565,0.07590741635883519,"['FZD1', 'JUN', 'FRAT2', 'NOTUM', 'DKK1']",0.9994944828815825,0,0,5
398,One-carbon metabolism WP241,0.891810466044743,0.44800459374102786,0.051297265635459346,['MAT2B'],0.9994944828815825,0,0,1
399,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8943875321223246,0.5665396933229814,0.06323496047597464,"['ACTB', 'ACTG1', 'CACNG5']",0.9994944828815825,0,0,3
400,Focal Adhesion WP306,0.8992648117969316,0.6975222572683011,0.07406132659764882,"['SHC4', 'JUN', 'LAMB3', 'BAD', 'FN1', 'ELK1', 'ACTB', 'MYL12B', 'ACTG1', 'MAPK3']",0.9994944828815825,0,0,10
401,Autophagy WP4923,0.9000779197267319,0.43197674418604654,0.045475894683110855,['ATG101'],0.9994944828815825,0,0,1
402,Sphingolipid pathway WP1422,0.9000779197267319,0.43197674418604654,0.045475894683110855,['SERINC1'],0.9994944828815825,0,0,1
403,Trans-sulfuration and one-carbon metabolism WP2525,0.9000779197267319,0.43197674418604654,0.045475894683110855,['MAT2B'],0.9994944828815825,0,0,1
404,Pathways Regulating Hippo Signaling WP4540,0.9020418639001477,0.5893456137358576,0.06075820161228529,"['NTRK1', 'PRKCH', 'PRKAR1A', 'FGFR4']",0.9994944828815825,0,0,4
405,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9077140434447667,0.4170542635658915,0.040381646122836186,['LPL'],0.9994944828815825,0,0,1
406,Phosphodiesterases in neuronal function WP4222,0.9092731936269197,0.49340574088440653,0.04692766553745905,"['ADCY10', 'PDE10A']",0.9994944828815825,0,0,2
407,Fluoropyrimidine Activity WP1601,0.9147670129493213,0.4031266149870801,0.03591288795229336,['CYP2A6'],0.9994944828815825,0,0,1
408,The influence of laminopathies on Wnt signaling WP4844,0.9147670129493213,0.4031266149870801,0.03591288795229336,['CEBPB'],0.9994944828815825,0,0,1
409,Wnt signaling in kidney disease WP4150,0.9147670129493213,0.4031266149870801,0.03591288795229336,['FZD1'],0.9994944828815825,0,0,1
410,Zinc homeostasis WP3529,0.9147670129493213,0.4031266149870801,0.03591288795229336,['SLC30A2'],0.9994944828815825,0,0,1
411,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9251379663686005,0.46485051023452884,0.03617113373146003,"['CDK5', 'H2AFX']",0.9994944828815825,0,0,2
412,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9298173184844392,0.4560504706002898,0.03318549020489295,"['CALM1', 'CALM2']",0.9994944828815825,0,0,2
413,Endochondral Ossification WP474,0.9298173184844392,0.4560504706002898,0.03318549020489295,"['CALM1', 'CALM2']",0.9994944828815825,0,0,2
414,T-cell receptor (TCR) signaling pathway WP69,0.932469912365665,0.5033320393374742,0.03519216760986236,"['JUN', 'FOS', 'MAPK3']",0.9994944828815825,0,0,3
415,Target Of Rapamycin (TOR) Signaling WP1471,0.9328553087475857,0.36640826873385013,0.025467269700048045,['RRAGA'],0.9994944828815825,0,0,1
416,Bladder cancer WP2828,0.937988020282209,0.355608755129959,0.022765397419890556,['CDKN1A'],0.9994944828815825,0,0,1
417,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9427286412037773,0.3454263565891473,0.020372140782366925,['GABRQ'],0.9994944828815825,0,0,1
418,Hedgehog Signaling Pathway WP4249,0.9471071018217591,0.3358096468561585,0.018248935972942356,['EVC'],0.9994944828815825,0,0,1
419,DNA Repair Pathways Full Network WP4946,0.9544072101184827,0.5292147553954871,0.02469572909319075,"['FEN1', 'CENPX', 'CETN2', 'H2AFX', 'POLE3']",0.9994944828815825,0,0,5
420,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9549512122677319,0.4585266137274943,0.021135796381846268,"['SHC4', 'BAD', 'MAPK3']",0.9994944828815825,0,0,3
421,Neural Crest Differentiation WP2064,0.9549512122677319,0.4585266137274943,0.021135796381846268,"['MIA', 'RHOB', 'DLL3']",0.9994944828815825,0,0,3
422,Thermogenesis WP4321,0.9549572499467315,0.49772907504866265,0.022939687990733724,"['ADCY10', 'CREB3', 'ACTB', 'ACTG1']",0.9994944828815825,0,0,4
423,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.955038495660523,0.5524697775269551,0.025415615077750125,"['FZD1', 'CLDN20', 'CLDN9', 'FN1', 'DLL3', 'MAPK3']",0.9994944828815825,0,0,6
424,AMP-activated protein kinase (AMPK) signaling WP1403,0.9555981968395536,0.4026635634859064,0.018288073250920474,"['CDKN1A', 'LEPR']",0.9994944828815825,0,0,2
425,Mesodermal commitment pathway WP2857,0.9566279694867937,0.5245790790452364,0.023260208673593023,"['PRKAR1A', 'BHLHE40', 'RPL38', 'DKK1', 'NODAL']",0.9994944828815825,0,0,5
426,Nephrotic syndrome WP4758,0.9583356114780487,0.3099185052673425,0.013189275349741651,['ARHGDIA'],0.9994944828815825,0,0,1
427,Pathways affected in adenoid cystic carcinoma WP3651,0.9584420914421163,0.3960370855536761,0.01681024325613035,"['INSRR', 'FGFR4']",0.9994944828815825,0,0,2
428,Splicing factor NOVA regulated synaptic proteins WP4148,0.9615216055989444,0.30215116279069765,0.011855880894565534,['NCDN'],0.9994944828815825,0,0,1
429,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.963614785496831,0.38341522282561846,0.014210773121659548,"['RBP4', 'LPL']",0.9994944828815825,0,0,2
430,Notch Signaling WP268,0.9644641327824806,0.29476271506901114,0.01066529164162141,['DLL3'],0.9994944828815825,0,0,1
431,Chemokine signaling pathway WP3929,0.9663182363232043,0.5025596163815449,0.017218728652013387,"['SHC4', 'GNG3', 'GNG8', 'CXCL5', 'MAPK3']",0.9994944828815825,0,0,5
432,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9671817848605417,0.2877260981912145,0.009601078284067676,['ATG101'],0.9994944828815825,0,0,1
433,Ectoderm Differentiation WP2858,0.9696019493435658,0.4942571960329399,0.015257548236852957,"['ARHGDIG', 'CCL2', 'JAKMIP1', 'VAX2', 'LY6E']",0.9994944828815825,0,0,5
434,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9696917349117656,0.2810167658193618,0.008648869034631274,['DHCR24'],0.9994944828815825,0,0,1
435,B Cell Receptor Signaling Pathway WP23,0.9720088401797277,0.4161490683229814,0.01181463007311996,"['JUN', 'CD81', 'ELK1']",0.9994944828815825,0,0,3
436,Wnt signaling pathway and pluripotency WP399,0.9736487661666958,0.41139363354037267,0.010986123020618662,"['FZD1', 'JUN', 'PRKCH']",0.9994944828815825,0,0,3
437,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9779541546082094,0.2570344713838034,0.00572993754113634,['MAPK3'],0.9994944828815825,0,0,1
438,Joubert Syndrome WP4656,0.9801557518883455,0.33529437117489874,0.006720569778701704,"['CETN2', 'ARL2']",0.9994944828815825,0,0,2
439,Allograft Rejection WP2328,0.9811982337466415,0.24651162790697675,0.00467897969680104,['HLA-DQB1'],0.9994944828815825,0,0,1
440,Interferon type I signaling pathways WP585,0.9826367123773739,0.24156589147286822,0.0042312192285109814,['SOCS3'],0.9994944828815825,0,0,1
441,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9826367123773739,0.24156589147286822,0.0042312192285109814,['ISG15'],0.9994944828815825,0,0,1
442,DNA IR-damage and cellular response via ATR WP4016,0.9848998874516527,0.3175656363562125,0.004831850101060654,"['FEN1', 'H2AFX']",0.9994944828815825,0,0,2
443,Hippo-Merlin Signaling Dysregulation WP4541,0.98740340029323,0.3617468944099379,0.004585724110914602,"['NTRK1', 'PRKAR1A', 'FGFR4']",0.9994944828815825,0,0,3
444,Integrin-mediated Cell Adhesion WP185,0.9946699868187762,0.2649638956853852,0.001416038168925735,"['CAPNS1', 'RHO']",0.9994944828815825,0,0,2
445,Fragile X Syndrome  WP4549,0.9948186660423655,0.31703579601176857,0.001646938699449814,"['PRKAR1A', 'AP2S1', 'AP2M1']",0.9994944828815825,0,0,3
446,Head and Neck Squamous Cell Carcinoma WP4674,0.9964680496232632,0.17232558139534884,0.000609722792416803,['CDKN1A'],0.9994944828815825,0,0,1
447,Genes related to primary cilium development (based on CRISPR) WP4536,0.9971762084537735,0.24097750193948797,0.0006814327983362475,"['EVC', 'DYNLL1']",0.9994944828815825,0,0,2
448,Ciliopathies WP4803,0.997465018142968,0.3600264478818413,0.0009138192610374311,"['DNAH11', 'RSPH4A', 'EVC', 'NEK2', 'CCDC65']",0.9994944828815825,0,0,5
449,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9993253858240299,0.20055598655288337,0.00013534356908410353,"['LPL', 'MAPK3']",0.9994944828815825,0,0,2
450,mRNA Processing WP411,0.9994944828815825,0.1940363872969794,9.811351649549844e-05,"['SF3B5', 'SNU13']",0.9994944828815825,0,0,2
